J G Franco1, C P Dias-Rocha1, T P Fernandes1, L Albuquerque Maia2, P C Lisboa2, E G Moura2, C C Pazos-Moura1, I H Trevenzoli3. 1. Laboratório de Endocrinologia Molecular, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373, sl G0-16, Cidade Universitária, Rio de Janeiro, RJ, 21941-902, Brazil. 2. Laboratório de Fisiologia Endócrina, Departamento de Ciências Fisiológicas, Instituto de Biologia Roberto Alcântara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil. 3. Laboratório de Endocrinologia Molecular, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373, sl G0-16, Cidade Universitária, Rio de Janeiro, RJ, 21941-902, Brazil. haraisis@biof.ufrj.br.
Abstract
PURPOSE: Perinatal high-fat diet is associated with obesity and metabolic diseases in adult offspring. Resveratrol has been shown to exert antioxidant and anti-obesity actions. However, the effects of resveratrol on leptinemia and leptin signaling are still unknown as well as whether resveratrol treatment can improve metabolic outcomes programmed by maternal high-fat diet. We hypothesize that resveratrol treatment in male rats programmed by high-fat diet would decrease body weight and food intake, and leptinemia with changes in central leptin signaling. METHODS: Female Wistar rats were divided into two groups: control group (C), which received a standard diet containing 9 % of the calories as fat, and high-fat group (HF), which received a diet containing 28 % of the calories as fat. Dams were fed in C or HF diet during 8 weeks before mating and throughout gestation and lactation. C and HF male offspring received standard diet throughout life. From 150 until 180 days of age, offspring received resveratrol (30 mg/Kg body weight/day) or vehicle (carboxymethylcellulose). RESULTS: HF offspring had increased body weight, hyperphagia and increased subcutaneous and visceral fat mass compared to controls, and resveratrol treatment decreased adiposity. HF offspring had increased leptinemia as well as increased SOCS3 in the arcuate nucleus of the hypothalamus, which suggest central leptin resistance. Resveratrol treatment rescued leptinemia and increased p-STAT3 content in the hypothalamus with no changes in SOCS3, suggesting improvement in leptin signaling. CONCLUSIONS: Collectively, our data suggest that resveratrol could reverse hyperleptinemia and improve central leptin action in adult offspring from HF mothers attenuating obesity.
PURPOSE: Perinatal high-fat diet is associated with obesity and metabolic diseases in adult offspring. Resveratrol has been shown to exert antioxidant and anti-obesity actions. However, the effects of resveratrol on leptinemia and leptin signaling are still unknown as well as whether resveratrol treatment can improve metabolic outcomes programmed by maternal high-fat diet. We hypothesize that resveratrol treatment in male rats programmed by high-fat diet would decrease body weight and food intake, and leptinemia with changes in central leptin signaling. METHODS: Female Wistar rats were divided into two groups: control group (C), which received a standard diet containing 9 % of the calories as fat, and high-fat group (HF), which received a diet containing 28 % of the calories as fat. Dams were fed in C or HF diet during 8 weeks before mating and throughout gestation and lactation. C and HF male offspring received standard diet throughout life. From 150 until 180 days of age, offspring received resveratrol (30 mg/Kg body weight/day) or vehicle (carboxymethylcellulose). RESULTS: HF offspring had increased body weight, hyperphagia and increased subcutaneous and visceral fat mass compared to controls, and resveratrol treatment decreased adiposity. HF offspring had increased leptinemia as well as increased SOCS3 in the arcuate nucleus of the hypothalamus, which suggest central leptin resistance. Resveratrol treatment rescued leptinemia and increased p-STAT3 content in the hypothalamus with no changes in SOCS3, suggesting improvement in leptin signaling. CONCLUSIONS: Collectively, our data suggest that resveratrol could reverse hyperleptinemia and improve central leptin action in adult offspring from HF mothers attenuating obesity.
Authors: R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer Journal: N Engl J Med Date: 1996-02-01 Impact factor: 91.245
Authors: J G Franco; T P Fernandes; C P D Rocha; C Calviño; C C Pazos-Moura; P C Lisboa; E G Moura; I H Trevenzoli Journal: J Physiol Date: 2012-08-06 Impact factor: 5.182
Authors: Rosiane Aparecida Miranda; Claudinéia Conationi da Silva Franco; Júlio Cezar de Oliveira; Luiz Felipe Barella; Laize Peron Tófolo; Tatiane Aparecida Ribeiro; Audrei Pavanello; Ellen Paula Santos da Conceição; Rosana Torrezan; James Armitage; Patrícia Cristina Lisboa; Egberto Gaspar de Moura; Paulo Cezar de Freitas Mathias; Elaine Vieira Journal: Endocrine Date: 2016-04-26 Impact factor: 3.633
Authors: Mariana Macedo de Almeida; Camilla P Dias-Rocha; Clara F Reis-Gomes; Haimei Wang; Aline Cordeiro; Carmen C Pazos-Moura; Lisa Joss-Moore; Isis H Trevenzoli Journal: Eur J Nutr Date: 2020-07-15 Impact factor: 5.614
Authors: Klaus N Fontes; Adriana Cabanelas; Flavia F Bloise; Cherley Borba Vieira de Andrade; Luana L Souza; Marianna Wilieman; Isis H Trevenzoli; Lais C Agra; Johnatas D Silva; Christianne Bandeira-Melo; Pedro L Silva; Patricia R M Rocco; Tania M Ortiga-Carvalho Journal: Front Physiol Date: 2017-10-25 Impact factor: 4.566